Article Text

Download PDFPDF
Clinical round up
  1. Sophie Herbert1,
  2. Lewis Haddow2
  1. 1The Ashwood Centre, St Mary's Hospital, Kettering, UK
  2. 2Centre for Sexual Health Research, University College London, London, UK
  1. Correspondence to Dr Sophie Herbert, The Ashwood Centre, St Mary's Hospital, Kettering, UK; sophieherbert{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Swabs for nucleic acid amplification test and culture

The rise of gonococcal resistance (particularly to extended-spectrum cephalosporins) poses an increasing problem. Wind et al1 look at the use of ESwab swabs for gonorrhoea testing. They highlight that a nucleic acid amplification test (NAAT) to diagnose gonorrhoea combined with a way to defer culture of positive samples would be useful, but a specialised collection medium to enable Neisseria gonorrhoea to survive, that also maintains diagnostic sensitivity would be essential. The ESwab system is known to prolong survival of many bacterial species. The authors hypothesised that ESwab could be used for deferred gonorrhoea culture and aimed to determine if culture was possible up to 3 days after storing samples and if ESwab NAAT testing resulted in any loss of diagnostic sensitivity. A total of 2452 samples were taken from 1893 high-risk patients (symptomatic, men who have sex with men (MSM) or sexually transmitted infection contacts) attending a sexual health clinic. In men, direct GC culture and first void urine or rectal NAAT (in MSM) …

View Full Text


  • Contributors SH chose the papers and wrote the manuscript. LH assisted.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.